CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Abroad (travel likely)RecruitingPHASE1
Conditions
Acute Myeloid Leukemia · Recurrent Adult Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia · Secondary Acute Myeloid Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope Medical Center, Duarte, California, United States
Contact: Principal Investigator (Karamjeet S. Sandhu)
Study leads
Karamjeet S Sandhu
Principal Investigator
City of Hope Medical Center